vs
Side-by-side financial comparison of Cellectis S.A. (CLLS) and INTERGROUP CORP (INTG). Click either name above to swap in a different company.
INTERGROUP CORP is the larger business by last-quarter revenue ($17.3M vs $9.5M, roughly 1.8× Cellectis S.A.). INTERGROUP CORP runs the higher net margin — 8.8% vs -265.9%, a 274.6% gap on every dollar of revenue. On growth, Cellectis S.A. posted the faster year-over-year revenue change (375.0% vs 19.8%). Cellectis S.A. produced more free cash flow last quarter ($27.6M vs $-481.0K).
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
CLLS vs INTG — Head-to-Head
Income Statement — Q2 FY2024 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $17.3M |
| Net Profit | $-25.3M | $1.5M |
| Gross Margin | — | — |
| Operating Margin | -181.1% | 11.6% |
| Net Margin | -265.9% | 8.8% |
| Revenue YoY | 375.0% | 19.8% |
| Net Profit YoY | -51.9% | 155.6% |
| EPS (diluted) | $-0.28 | $0.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $17.3M | ||
| Q3 25 | — | $17.9M | ||
| Q2 25 | — | $16.2M | ||
| Q1 25 | — | $16.8M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | — | $16.9M | ||
| Q2 24 | $9.5M | $13.4M | ||
| Q1 24 | — | $14.9M |
| Q4 25 | — | $1.5M | ||
| Q3 25 | — | $-535.0K | ||
| Q2 25 | — | $-2.2M | ||
| Q1 25 | — | $-578.0K | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | — | $-398.0K | ||
| Q2 24 | $-25.3M | $-4.9M | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | — | 11.6% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | — | 5.9% | ||
| Q3 24 | — | 18.5% | ||
| Q2 24 | -181.1% | 3.7% | ||
| Q1 24 | — | 4.8% |
| Q4 25 | — | 8.8% | ||
| Q3 25 | — | -3.0% | ||
| Q2 25 | — | -13.9% | ||
| Q1 25 | — | -3.4% | ||
| Q4 24 | — | -18.9% | ||
| Q3 24 | — | -2.4% | ||
| Q2 24 | -265.9% | -36.7% | ||
| Q1 24 | — | -21.3% |
| Q4 25 | — | $0.71 | ||
| Q3 25 | — | $-0.25 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-0.27 | ||
| Q4 24 | — | $-1.26 | ||
| Q3 24 | — | $-0.18 | ||
| Q2 24 | $-0.28 | — | ||
| Q1 24 | — | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $149.0M | $7.5M |
| Total DebtLower is stronger | — | $233.2M |
| Stockholders' EquityBook value | $148.6M | $-85.2M |
| Total Assets | $407.1M | $101.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $7.5M | ||
| Q3 25 | — | $6.0M | ||
| Q2 25 | — | $6.1M | ||
| Q1 25 | — | $4.8M | ||
| Q4 24 | — | $15.4M | ||
| Q3 24 | — | $12.2M | ||
| Q2 24 | $149.0M | $11.6M | ||
| Q1 24 | — | $19.5M |
| Q4 25 | — | $233.2M | ||
| Q3 25 | — | $237.8M | ||
| Q2 25 | — | $240.5M | ||
| Q1 25 | — | $241.5M | ||
| Q4 24 | — | $227.2M | ||
| Q3 24 | — | $218.1M | ||
| Q2 24 | — | $225.7M | ||
| Q1 24 | — | $225.0M |
| Q4 25 | — | $-85.2M | ||
| Q3 25 | — | $-86.7M | ||
| Q2 25 | — | $-86.1M | ||
| Q1 25 | — | $-84.5M | ||
| Q4 24 | — | $-83.9M | ||
| Q3 24 | — | $-80.9M | ||
| Q2 24 | $148.6M | $-80.3M | ||
| Q1 24 | — | $-76.4M |
| Q4 25 | — | $101.1M | ||
| Q3 25 | — | $102.5M | ||
| Q2 25 | — | $104.1M | ||
| Q1 25 | — | $103.2M | ||
| Q4 24 | — | $110.6M | ||
| Q3 24 | — | $109.3M | ||
| Q2 24 | $407.1M | $107.8M | ||
| Q1 24 | — | $119.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.9M | $-23.0K |
| Free Cash FlowOCF − Capex | $27.6M | $-481.0K |
| FCF MarginFCF / Revenue | 290.5% | -2.8% |
| Capex IntensityCapex / Revenue | 13.2% | 2.6% |
| Cash ConversionOCF / Net Profit | — | -0.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | $739.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-23.0K | ||
| Q3 25 | — | $-296.0K | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $-854.0K | ||
| Q4 24 | — | $-781.0K | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | $28.9M | $6.8M | ||
| Q1 24 | — | $1.9M |
| Q4 25 | — | $-481.0K | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | $27.6M | $2.7M | ||
| Q1 24 | — | $1.1M |
| Q4 25 | — | -2.8% | ||
| Q3 25 | — | -7.1% | ||
| Q2 25 | — | 22.5% | ||
| Q1 25 | — | -6.8% | ||
| Q4 24 | — | -7.8% | ||
| Q3 24 | — | 18.3% | ||
| Q2 24 | 290.5% | 20.4% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 13.9% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | 13.2% | 30.4% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLLS
Segment breakdown not available.
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
